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The significance of polymicrobial infections is increasingly being recognized especially in
a biofilm context wherein multiple bacterial species—including both potential pathogens
and members of the commensal flora—communicate, cooperate, and compete with
each other. Two important bacterial pathogens that have developed a complex
network of evasion, counter-inhibition, and subjugation in their battle for space and
nutrients are Pseudomonas aeruginosa and Staphylococcus aureus. Their strain- and
environment-specific interactions, for instance in the cystic fibrosis lung or in wound
infections, show severe competition that is generally linked to worse patient outcomes.
For instance, the extracellular factors secreted by P. aeruginosa have been shown to
subjugate S. aureus to persist as small colony variants (SCVs). On the other hand, data
also exist where S. aureus inhibits biofilm formation by P. aeruginosa but also protects the
pathogen by inhibiting its phagocytosis. Interestingly, such interspecies interactions differ
between the planktonic and biofilm phenotype, with the extracellular matrix components
of the latter likely being a key, and largely underexplored, influence. This review attempts
to understand the complex relationship betweenP. aeruginosa andStaphylococcus spp.,
focusing on S. aureus, that not only is interesting from the bacterial evolution point of view,
but also has important consequences for our understanding of the disease pathogenesis
for better patient management.
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INTRODUCTION
Over the past decade there is a growing appreciation that the biofilm mode of growth is the
most common lifestyle adopted by bacteria (Hall-Stoodley et al., 2004; Burmolle et al., 2014).
Biofilms can be defined as surface-associated, structured bacterial communities embedded in an
extracellular matrix (Hall-Stoodley et al., 2004). Living in a biofilm provides protection in a stressful
environment where mechanical stress, desiccation, and biocides are common threats (Donlan and
Costerton, 2002; Flemming and Wingender, 2010). Multiple species frequently exist together in
a single biofilm, where they either improve the fitness of one another or compete for space and
nutrients (Jefferson, 2004; Billings et al., 2013; Burmolle et al., 2014; DeLeon et al., 2014). Most
bacteria have developed interaction strategies to communicate within and between species in a
cell density-dependent manner, for example, by using small diffusible molecules in a process called
quorum-sensing (Federle and Bassler, 2003; Li and Tian, 2012). Furthermore, many bacteria excrete
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antimicrobial components, also often regulated by quorum-
sensing, to eliminate competitors (Federle and Bassler, 2003; Li
and Tian, 2012). Indeed, these multispecies interactions within
the biofilm are important for the inhabiting bacteria and, given
the increasing evidence of the link between biofilm-associated
pathogens and disease, also from a clinical point of view (Donlan
and Costerton, 2002; Li and Tian, 2012).
S. aureus and P. aeruginosa are important pathogens causing
a wide variety of infections, including pneumonia in cystic
fibrosis (CF) patients, healthcare associated pneumonia and
chronic wounds (Harrison, 2007; Fazli et al., 2009; Cystic
Fibrosis Foundation Patient Registry, 2012). Initially, only an
antagonistic relationship between both organisms was described
as the presence of one is associated with the absence of the other
in CF and both are rarely found in close association in chronic
wounds. S. aureus mostly resides on the wound surface whereas
P. aeruginosa is found in the deep layers (Kirketerp-Moller et al.,
2008; Fazli et al., 2009). We also recently showed a negative
correlation between presence of P. aeruginosa and the total
species diversity in in vivo endotracheal tube biofilms and a low
co-occurrence of P. aeruginosa with Staphylococcus epidermidis
(Hotterbeekx et al., 2016). Nonetheless, recent studies have also
co-isolated P. aeruginosa and Gram-positive bacteria, including
S. aureus, from the same infection site where increased virulence
and/or antibiotic resistance is described (Duan et al., 2003;
Kirketerp-Moller et al., 2008; Fazli et al., 2009; Dalton et al.,
2011; Korgaonkar et al., 2013). After describing first in vivo
observations occurring in human diseases, we will discuss
and summarize in vitro data from the current literature on
potential mechanisms of interactions between P. aeruginosa and
Staphylococcus spp., primarily S. aureus.
CO-OCCURRENCE OF P. AERUGINOSA
AND S. AUREUS IN VIVO IS LINKED TO
WORSE DISEASE OUTCOMES
CF is a typical example of a biofilm-related infection wherein P.
aeruginosa and S. aureus are frequently isolated from the lungs
of these patients (Harrison, 2007; Hauser et al., 2011; Cystic
Fibrosis Foundation, 2014). While, S. aureus is mostly acquired
during childhood, the presence of P. aeruginosa is associated
with increasing age and worsening patient prognosis (Sagel et al.,
2009; Hauser et al., 2011; Cystic Fibrosis Foundation, 2014).
An increasing incidence of P. aeruginosa with age has been
shown to coincide with a decreasing S. aureus incidence in CF
patients (Harrison, 2007; Cystic Fibrosis Foundation, 2014), data
that primarily indicates an antagonistic relationship between
the two pathogens. However, in cases where P. aeruginosa
and S. aureus have been co-isolated, both pathogens seem
to contribute independently and additively to the disease
severity (Sagel et al., 2009; Hauser et al., 2011), presenting
as increased lung inflammation and consequently increased
lung damage compared to infection with a single pathogen
(Sagel et al., 2009). Furthermore, due to repeated antibiotic
therapy, CF patients also carry higher levels of methicillin-
resistant S. aureus (MRSA) that is associated with a worse lung
function compared to methicillin- sensitive S. aureus (MSSA)
but only in combination with P. aeruginosa (Hubert et al.,
2013).
Chronic wounds are another example of biofilm-related
infections wherein co-presence of P. aeruginosa and S. aureus
has been shown to result in delayed wound healing compared
to single species infections (Dalton et al., 2011; Seth et al.,
2012; Pastar et al., 2013). In a pig wound model, infections
initiated by in vitro preformed dual species biofilm caused a
significant suppression of keratinocyte growth factor 1 (KGF1),
which is responsible for re-epithelialization and wound closure
(Pastar et al., 2013). In a rabbit ear-wound model, mixed
species infection of S. aureus and P. aeruginosa caused an
increased expression of the pro-inflammatory cytokines IL-1β
and TNF-α, indicating a higher inflammatory response compared
to single species infection (Seth et al., 2012). Moreover, S.
aureus and P. aeruginosa reached an equilibrium after 12
days of infection, with P. aeruginosa being the dominant
pathogen (Seth et al., 2012). In a mouse chronic wound
model infected with in vitro preformed four-species biofilm
and monitored up to 12 days, presence of multiple species
was found to significantly delay wound healing only at 8 days
post-infection (Dalton et al., 2011). However, polymicrobial
infections showed increased antimicrobial tolerance compared
to single species infection with P. aeruginosa in this study
(Dalton et al., 2011). These studies suggest that, despite the
constraints of different host backgrounds, multispecies infections
can lead to delayed wound healing, increased inflammation
and increased antibiotic tolerance, which all add to a worse
patient outcome. P. aeruginosa is often the dominant pathogen
due to its wide array of mechanisms to adapt to changing
hostile environments, which allows colonization in a variety
of niches. When P. aeruginosa encounters other bacteria
like S. aureus, it can co-exist or take over the biofilm
through production of various quorum-sensing regulated factors.
Section Extracellular products of Staphylococcus spp. impact P.
aeruginosa virulence in vivo discusses in vivo animal studies
exploring production of P. aeruginosa virulence factors in the
presence of S. aureus.
EXTRACELLULAR PRODUCTS OF
STAPHYLOCOCCUS SPP. IMPACT
P. AERUGINOSA VIRULENCE IN VIVO
P. aeruginosa possesses a wide range of extracellular factors
to survive and invade human tissues, often by modulating the
immune system. The complex interplay between biofilms and
the host immune response are reviewed in detail by Watters
et al. (2016). Here, we discuss four molecules in particular which
are upregulated in the presence of Gram-positive bacteria: LasB
elastase, rhamnolipids, exotoxins, and phenazines (Figure 1).
LasB elastase is an extracellular protease capable of digesting the
lung surfactant, the pulmonary antimicrobial enzyme lysozyme,
and transferrin, as well as slowing down the ciliary movement
(Hauser, 2009). In addition, LasB impairs uptake of P. aeruginosa
by macrophages and its protease activity leads to lung tissue
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FIGURE 1 | Interactions in the cystic fibrosis lung. The complex interplay between microbial competition and the human immune system results in increased
secretion of pro-inflammatory cytokines, microbial virulence factors and consequently tissue damage and bacterial invasion of the epithelial barrier. Mixed species
infections lead to a stronger decrease in ciliary beating and increased goblet cell hyperplasia and tissue fibrosis, which are characteristic of cystic fibrosis disease
progression. PQS, Pseudomonas quinolone signal; T3SS, type 3 secretion system; AI-2, autoinducer 2.
damage, thereby decreasing pulmonary function and facilitating
dissemination into the bloodstream (Strateva and Mitov, 2011).
Similar to LasB, rhamnolipids are glycolipidic biosurfactants that
interfere with the lung surfactant activity by solubilizing the
phospholipids and with airway immune response by disrupting
the polymorphonuclear leucocyte chemotaxis and macrophage
function, and also inhibit ciliary beating (Soberon-Chavez et al.,
2005; Jensen et al., 2007). Furthermore, rhamnolipids increase
inflammation by stimulating the release of the pro-inflammatory
cytokines IL-6 and IL-8 by the airway epithelium (Soberon-
Chavez et al., 2005). An excessive inflammatory response and
associated tissue damage is also induced by the release of
exotoxins ExoT, ExoS, and ExoY by the type III secretion
system. The type III secretion system is a needle-like structure
directly injecting exotoxins into other bacteria, macrophages
and epithelial cells, thereby killing them (Hauser, 2009). The
fourth type of molecules, phenazines, are pigments produced by
a large number of Pseudomonas spp., and have been shown to
be involved in mediating microbial interactions as well as in CF
disease progression. Pyocyanin is the most important phenazine
and its production in the CF lung was shown to lead to goblet
cell hyperplasia, airway fibrosis and alveolar airspace destruction
(Caldwell et al., 2009; Strateva and Mitov, 2011). Pyocyanin
causes an imbalance between the T helper type 1 (Th1) and type 2
(Th2) cytokines, leading to overproduction of Th2 cytokines IL-4
and IL-13 and increased macrophage infiltration (Caldwell et al.,
2009). Essentially, release of these extracellular molecules by P.
aeruginosa, partly in response to the presence of S. aureus, leads
to increased tissue damage due to their cytotoxic and immune-
modulatory effects, which also helps P. aeruginosa survival.
Interestingly, not only S. aureus but Gram-positive commensals
(coagulase negative staphylococci and viridans streptococci) can
also alter the virulence of P. aeruginosa in a similar fashion
(Duan et al., 2003). Such immune modulation and evasion
by collective bacterial species might underlie the worsened
patient prognosis observed in multispecies infections (Figure 1).
Sections AI-2 in the CF Lung Increases P. aeruginosa Virulence
and Might Be an Important Therapeutic Target and N-Acetyl
Glucosamine Sensing Enhances the Production of P. aeruginosa
Extracellular Virulence Factors discuss the known mechanisms
of how extracellular products of staphylococci modulate the
four major virulence factors P. aeruginosa that were discussed
above.
AI-2 in the CF Lung Increases
P. aeruginosa Virulence and Might Be an
Important Therapeutic Target
Autoinducer-2 (AI-2) is a small diffusible quorum-sensing
molecule produced by several bacteria, including staphylococci,
and has been shown to cause upregulation of several major
virulence genes of P. aeruginosa discussed above, including
extracellular protease (lasB), rhamnosyltransferase involved
in rhamnolipid synthesis (rhlA), exotoxins (exoT, exoS, exoY)
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3 April 2017 | Volume 7 | Article 106
Hotterbeekx et al. Interactions between P. aeruginosa and Staphylococci
and phenazines (phzA1 and phzA2; Li et al., 2015). Induction
of P. aeruginosa virulence by AI-2 was shown both in vitro
after screening of a random lux reporter-based promotor
library and in vivo in rat lung infection and Drosophila chronic
infection models (Duan et al., 2003; Sibley et al., 2008; Li et al.,
2015). AI-2 mediated quorum-sensing is now recognized
as a universal language of interspecies communication
regulating a wide variety of genes involved in virulence and
biofilm formation in a cell-density dependent manner in a
number of micro-organisms, including non-producers like
P. aeruginosa (Rezzonico et al., 2012). Furthermore, AI-2
has been detected in substantial amounts in the sputum
of CF patients and in infected rats (Duan et al., 2003),
raising the possibility of interruption of AI-2 signaling to
either slow down disease progression or hasten the healing
process.
A promising approach is the use of AI-2 analogs like
D-ribose that block the AI-2 pathway and inhibit P. aeruginosa
virulence. Wang et al showed in a rat model of mechanical
ventilation that co-inoculation of P. aeruginosa and Streptococcus
mitis resulted in increased biomass, lung damage, and rat
mortality compared to infection with only P. aeruginosa
(Wang et al., 2016). Treatment with D-ribose of both
the single and dual species infections showed a significant
decrease in biomass and lowering of rat mortality in the
latter group due to interference with AI-2 signaling (Wang
et al., 2016). Inhibition of P. aeruginosa virulence is not
only beneficial because the P. aeruginosa-mediated damage is
reduced but also because the immune system is less stimulated
(Figure 1). Further studies showing the benefits of non-toxic
biofilm inhibitors such as D-ribose in patient populations are
awaited.
N-Acetyl Glucosamine Sensing Enhances
the Production of P. aeruginosa
Extracellular Virulence Factors
Another molecule that increases the virulence of P. aeruginosa
and is commonly found in the CF lung is N-acetyl glucosamine
(GlcNAc). GlcNAc is part of the Gram-positive cell wall polymer
peptidoglycan and induces the virulence of P. aeruginosa
by enhancing the Pseudomonas quinolone signal (PQS),
which controls the production of extracellular virulence
factors like pyocyanin, elastase, rhamnolipids and HQNO
(discussed in Section Pseudomonas Quinolone Signal
Regulates the Production of Anti-Staphylococcal 4-Hydroxy-
2-Heptylquinoline N-Oxide (HQNO); Deziel et al., 2004;
Williams and Camara, 2009; Jimenez et al., 2012; Korgaonkar
et al., 2013; Figures 1, 2). The PQS, with 2-heptyl-3-hydroxy-
4-quilonone as the main effector molecule, is one of the
three quorum-sensing systems present in P. aeruginosa. PQS
is positively regulated by LasR and negatively regulated by
RhlR, the two other quorum-sensing systems of P. aeruginosa
with N-acylhomoserine lactone as main effector molecule
(Jimenez et al., 2012). P. aeruginosa has the ability to sense
the peptidoglycan shed by the Gram positive commensal flora
and in response increase the production of antimicrobials. The
enhanced virulence in the presence of GlcNAc from Gram-
positive bacteria was demonstrated in vivo in a Drosophila and
Galleria mellonella infection model (Korgaonkar et al., 2013;
Whiley et al., 2014). Both GlcNAc and AI-2 sensing are examples
where P. aeruginosa can sense its environment and generate
the appropriate response to eliminate competitors by producing
several virulence factors, which also has a negative impact on the
host.
P. AERUGINOSA PRODUCES A WIDE
VARIETY OF MOLECULES THAT INHIBIT
S. AUREUS IN VITRO
P. aeruginosa produces many molecules to compete with
other microorganisms for space and nutrients. The number
of molecules, quantities produced and even the structure of
these molecules vary between different strains of P. aeruginosa
as well as between different growth conditions (planktonic vs.
biofilm; the presence of host factors, antibiotics etc.). In order
to achieve a better understanding of complex interplay of the
different compounds in in vivo biofilm-related infections, it
is necessary to dissect this complex system into individual
subsystems and investigate each compound individually. In
the following sections, we discuss the effect of different
molecules produced by P. aeruginosa on S. aureus in vitro.
An overview of the extracellular molecules produced by
P. aeruginosa and their effect on S. aureus is shown in
Figure 2.
Pseudomonas Quinolone Signal Regulates
the Production of Anti-Staphylococcal
4-Hydroxy-2-Heptylquinoline N-Oxide
(HQNO)
P. aeruginosa strongly reduces or completely outcompetes
S. aureus during co-culture in many in vitro model systems,
both planktonic and biofilm (Palmer et al., 2005; Baldan et al.,
2014; DeLeon et al., 2014). This anti-staphylococcal activity of
P. aeruginosa was first described by Lightbown and Jackson
(1956), who identified 4-hydroxy-2-heptylquinoline N-oxide
(HQNO) as a major compound produced by P. aeruginosa that
inhibited the cytochrome systems of some bacteria, including S.
aureus (Lightbown and Jackson, 1956). The same phenomenon
was again described by Machan et al. in 1991 by testing the
culture supernatant of fifty P. aeruginosa clinical isolates on
261 staphylococci (Machan et al., 1991). The growth of all
staphylococci was reduced by each of the P. aeruginosa strains,
although the extent of inhibition was strain-dependent. The
factor responsible for this phenomenon was again identified as
HQNO (Machan et al., 1992). HQNO is the major compound
produced by the pqsABCDE operon, which is regulated by the
quorum-sensing system PQS. Although HQNO is described
as an antistaphylococcal compound, it has no lytic activity
against S. aureus itself but rather slows down the growth by
inhibiting oxidative respiration (Figure 2, right upper panel;
Williams and Camara, 2009). Exposure to an HQNO source
suppresses the growth of S. aureus, resulting in small colonies
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FIGURE 2 | Small molecules secreted by P. aeruginosa and S. aureus. Extracellular factors produced by P. aeruginosa affect biofilm formation, oxidative
respiration, cell lysis and virulence of S. aureus. Lysis of S. aureus leads to increased extracellular iron and N-acetyl glucosamine (GlcNac), which are sensed by
P. aeruginosa. AHL, N-acyl homoserine lactone; HQNO, 4-hydroxy-2-heptylquinoline N-oxide; PQS, Pseudomonas quinolone signal; GlcNac, N-acetyl glucosamine.
which are easily missed in diagnostic cultures (Hoffman et al.,
2006). These so-called SCVs represent a different phenotype
with specific characteristics and will be discussed later in
this review. Furthermore, HQNO can be detected at active
concentrations in the sputum of CF patients infected with
P. aeruginosa, suggesting that HQNO has the same effect in
the lungs of CF patients as it has in vitro (Hoffman et al.,
2006). Although HQNO is one of the most important and well-
studied antistaphylococcal compounds, it is not the only factor
slowing down the growth and inhibiting oxidative respiration in
staphylococci.
Pyocyanin Inhibits Oxidative Respiration in
S. aureus
Pyocyanin is one of the numerous pigmented phenazines
produced by P. aeruginosa and an important virulence
factor. Pyocyanin is produced during Pseudomonas biofilm
formation, has a role in acute and chronic airway infections,
enables anaerobic survival and serves as a redox-active
antimicrobial compound (Biswas et al., 2009; Caldwell et al.,
2009). Furthermore, by its inter-and intracellular signaling,
pyocyanin enables P. aeruginosa to successfully compete with
other bacteria and even fungi (Gibson et al., 2009; Toyofuku et al.,
2010; Tashiro et al., 2013). Like HQNO, pyocyanin also blocks
the oxidative respiration and inhibits growth of S. aureus, also
selecting for the SCV phenotype (Biswas et al., 2009; Figure 2,
right upper panel). The production of pyocyanin can be observed
after 8 h of culture, around the same time when a strong
reduction of S. aureus cells occurs during co-culture (Biswas
et al., 2009; Tashiro et al., 2013). Furthermore, the presence
of Gram-positive organisms, including some Staphylococcus
spp., can induce pyocyanin production in P. aeruginosa by
stimulating the PQS system (Korgaonkar and Whiteley, 2011;
Whiley et al., 2014; Figure 2, middle panel). In addition,
exposure to pyocyanin in the airways leads to pulmonary damage
and contributes to CF pathogenesis (Caldwell et al., 2009).
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Therefore, pyocyanin seems to be an antagonistic compound
secreted to provide a competitive advantage to P. aeruginosa by
harming S. aureus, other Gram-positive bacteria as well as the
host.
LasA Protease or Staphylolysin Effectively
Lyses S. aureus Cells
P. aeruginosa secretes a staphylolytic endopeptidase called LasA
protease or staphylolysin, which degrading pentaglycine in
the cell wall of S. aureus causing cell lysis (Kessler et al.,
1993). P. aeruginosa might use LasA protease to compete
with staphylococci but also to acquire iron from S. aureus
(Mashburn et al., 2005; Figure 2, left lower panel). Because freely
available iron is often limited, P. aeruginosa has developed several
strategies to scavenge iron, like the synthesis of iron chelating
siderophores, pyoverdin, and pyochelin (Diggle et al., 2007).
Transcription patterns of iron-regulated genes of P. aeruginosa
in the presence of S. aureus in vivo are the same as in high-
iron conditions in vitro, suggesting that S. aureus might be
an iron source for P. aeruginosa (Mashburn et al., 2005).
This type of interaction is, however, only important when
both species are located close together, like in multi-species
biofilms (Mashburn et al., 2005). The specificity of the LasA
protease for staphylococci makes it a potential therapeutic
candidate against staphylococcal infections especially those
cause by antibiotic resistant MRSA strains as shown in a rat
model of endophthalmitis (Barequet et al., 2009). However,
S. aureus can survive LasA by the emergence of L-form-like
colonies, which lack a cell wall (Falcon et al., 1989), although
the role of L-form like colonies in disease remains rather
vague.
Cis-2-Decenoic Acid Induces Biofilm
Dispersal in a Broad Range of Organisms
Including P. aeruginosa
Interspecies competition in biofilms not only occurs by inhibiting
or killing the other species but also by inducing its dispersal.
Biofilm dispersal is mainly induced when the environment
becomes less favorable, like in case of nutrient depletion, and
is extensively reviewed by Petrova and Sauer (2016). The
exact mechanisms that induce biofilm dispersal are currently
unknown, although several factors have been investigated (Hall-
Stoodley and Stoodley, 2005; Davies and Marques, 2009). Since
most bacteria reside in a biofilm consisting of multiple species
in vivo, the dispersal signal must be recognized by a wide
range of species (Davies and Marques, 2009). One class of
such molecules are the cis-monosaturated fatty acids, which
are small extracellular messenger molecules with broad inter-
phylum and even inter-kingdom activities (Davies and Marques,
2009). P. aeruginosa produces cis-2-decenoic acid, which induces
a dispersion response in biofilms formed by a range of
Gram-negative and Gram-positive bacteria, including S. aureus
(Figure 2, left upper panel), yeast as well as in P. aeruginosa
(Davies and Marques, 2009). Interestingly, Davies et al showed
that dispersion was only induced when the microcolonies
reached a minimum of 40µm diameter and 10µm of thickness,
indicating that a certain threshold concentration is needed for cis-
2-decenoic acid to become active (Davies and Marques, 2009).
This molecule could possibly be employed to disrupt biofilms
on surfaces, followed by disinfectants that can successfully clear
planktonic bacteria.
Rhamnolipids Promote Biofilm Dispersal
and Inhibit Adhesion
Most P. aeruginosa strains produce rhamnolipids, biosurfactants
consisting of one or two rhamnose molecules linked to one
or two fatty acids (Soberon-Chavez et al., 2005). While cis-2-
decenoic acid is mainly used as a common signal for dispersion
at the final biofilm stages, rhamnolipids are used to dislodge
competing bacteria from the biofilm.Many different rhamnolipid
homologs are produced, depending on the Pseudomonas strain
and carbon source, and their synthesis is quorum-sensing
regulated (Soberon-Chavez et al., 2005). Rhamnolipids were
shown to reduce the surface tension and to have an anti-
adhesive and antimicrobial effect on many micro-organisms
(Haba et al., 2003; Rodrigues et al., 2006; Zezzi do Valle Gomes
and Nitschke, 2012). The amphiphilic nature of rhamnolipids
enables them to intercalate into the cell membranes of different
microorganisms and form complexes, thereby permeabilizing
the membranes and causing leakage of intracellular material
(Sotirova et al., 2008). Gram-positive organisms seem more
susceptible to rhamnolipid permeabilization than Gram-negative
because the presence of lipopolysaccharides protects the cell
membranes of the latter against the effect of surfactants
(Soberon-Chavez et al., 2005). Furthermore, rhamnolipids
were shown to promote biofilm dispersal in many different
microorganisms, including P. aeruginosa itself, although this
effect is strain dependent (Rodrigues et al., 2006). For S.
aureus and S. epidermidis, rhamnolipids were shown to
induce biofilm dispersal and to inhibit adhesion in a dose-
dependent manner (Rodrigues et al., 2006; Zezzi do Valle Gomes
and Nitschke, 2012; Pihl et al., 2013; Figure 2, left upper
panel).
Long-Chain AHLs Reduce Growth and
Virulence of S. aureus
The N-acylhomoserine lactone (AHL) system is the most
important and most extensively studied quorum-sensing system
in P. aeruginosa. Many diverse AHLs are produced by various
Gram-negative bacteria, all consisting of a homoserine lactone
ring that is N-acylated with a fatty acyl group (Jimenez et al.,
2012). The length of the acyl chains may vary from 4 to 18
carbons and P. aeruginosa mainly produces a short-chain C4-
HSL and a long-chain 3-oxo-C12-HSL, although other lengths
might also occur (Jimenez et al., 2012). The production of
many virulence factors is regulated by AHL, including that of
pyocyanin and rhamnolipids (Jimenez et al., 2012). Although it
is currently not described that Gram-positive bacteria produce
AHLs, they might still be influenced by them (Qazi et al.,
2006). For example, growth of S. aureus is inhibited by several
long chain 3-oxo-AHLs (including C8, C10, C12, and C14
chains) in a concentration dependent manner, with C12 and C14
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being the most effective (Qazi et al., 2006). At concentrations
below growth inhibition, the function of staphylococcal accessory
regulator sarA and accessory gene regulator agr are strongly
reduced (see Section SCV Induction by P. aeruginosa is Sigma B
Dependent), and consequently their dependent virulence factors
like hemolysins, TSST-1, protein A, and fibronectin-binding
proteins (Figure 2, right lower panel; Qazi et al., 2006).Moreover,
inhibition of agr might lead to more biofilm formation in S.
aureus due to reduced detachment, although this study only
tested planktonic conditions and requires further research (Qazi
et al., 2006). The short chain AHL produced by P. aeruginosa
seems to have no effect on growth and agr expression of
S. aureus (Qazi et al., 2006). Furthermore, long-chain AHLs
produced by other Gram-negative bacteria are likely to have
similar effects in S. aureus, although, again, more studies are
required here.
P. aeruginosa Might also Cause Increased
Expression of S. aureus Virulence Factors
As described before, wounds infected with both S. aureus and
P. aeruginosa generally show delayed closure compared to the
single species infected wounds (Dalton et al., 2011; Seth et al.,
2012). In addition to host related factors, one of the reasons
for this phenomenon might be the upregulation of S. aureus
virulence factors during co-infection, as was demonstrated for
the MRSA strain USA300 (Pastar et al., 2013). Interestingly,
although the growth of USA300 was strongly inhibited by
P. aeruginosa in vitro, this effect was much weaker in vivo
(Pastar et al., 2013). Furthermore, co-infection of wounds in a pig
model induced S. aureus virulence factors hla and pvl, encoding
α-hemolysin and Panton-Valentine leucocidin (Figure 2, right
lower panel; Pastar et al., 2013). Another example of increased
virulence of S. aureus in the presence of P. aeruginosa is the
induction of staphyloxanthin production observed in a white
S. aureus variant isolated from a soft tissue wound (Antonic et al.,
2013). This strain possessed an intact and functional crtOPQMN
operon, which is essential for production of the staphyloxanthin
pigment, but was unable to induce pigment production on its
own. Interestingly, staphyloxanthin production was induced by
a P. aeruginosa co-isolate (Antonic et al., 2013). Furthermore,
the pigment production in a characteristically golden-yellow
S. aureus strain, which was co-isolated with the Pseudomonas
strain and the white S. aureus variant, remained unaffected.
However, this contradicts other studies that report an inhibition
of S. aureus pigment production by pyocyanin and pyoverdin
produced by P. aeruginosa (Biswas et al., 2009). Another result
of this study (Antonic et al., 2013) that is in contradiction with
other studies is that there was an unchanged expression of sigB
that encodes the alternative transcription factor sigma B and
which is previously reported to be upregulated in the presence of
P. aeruginosa (Mitchell et al., 2010). The discrepancies in results
between different studies indicate the importance of co-evolution
and adaptation of the different isolates to each other and their
environment. Adaptation of S. aureus to P. aeruginosa might
lead to an expression pattern that is similar to a stress-resistant
phenotype.
S. AUREUS SURVIVES IN THE PRESENCE
OF P. AERUGINOSA AS THE SMALL
COLONY VARIANT PHENOTYPE
As a defense mechanism, S. aureus has also devised strategies
to survive in the presence of P. aeruginosa. One of these is
the switch to the SCV, a well-characterized phenotype detected
in various diseases, including CF and device-related infections
(Proctor et al., 2006). SCVs appear as small, smooth colonies
on a culture plate and grow significantly slower compared to
wild type colonies. The SCV phenotype might appear naturally
and is caused by a defective or inhibited electron transport
pathway that switches S. aureus to a fermentative growth state.
In addition to a decreased growth rate, SCVs also demonstrate
decreased ATP yield, decreased pigmentation and often hemin or
menadione auxotrophy (Proctor et al., 2006; Biswas et al., 2009).
Remarkably, the switch to a SCV phenotype increases survival
of S. aureus in unfavorable conditions as it exhibits an increased
aminoglycoside resistance, biofilm formation, and intracellular
survival (Hoffman et al., 2006; Proctor et al., 2006; Biswas et al.,
2009; Atalla et al., 2011). Prolonged co-culture with P. aeruginosa
or exposure to pure HQNO leads to a high proportion of stable
S. aureus SCVs, an effect that is increased by the presence of
aminoglycosides (Hoffman et al., 2006). It has also been proposed
that the reason why S. aureus and P. aeruginosa are not frequently
detected together in diagnostic cultures of sputum of CF patients
is because of the existence of S. aureus as SCVs that are more
difficult to detect due to their small size and fastidious growth
requirements (Proctor et al., 2006; Atalla et al., 2011).
SCV Induction by P. aeruginosa Is Sigma B
Dependent
After the induction of the SCV phenotype during exposure to
HQNO, the expression of three main regulatory mechanisms of
virulence and biofilm formation is altered. First, the alternative
transcription factor sigma B (SigB) is upregulated (Mitchell et al.,
2010). SigB regulates the general stress response of Gram-positive
bacteria, repressing the expression of most exoenzymes and
toxins, stimulating the expression of adhesins and promoting
the persistence of S. aureus in host cells (van Schaik and Abee,
2005; Atalla et al., 2011). Second, stimulation of SigB was
shown to stimulate the expression of the Staphylococcal accessory
regulator SarA, which modulates the expression of the pore-
forming toxin α-hemolysin (hla) and increases biofilm formation
(Valle et al., 2003; Oscarsson et al., 2006; Mitchell et al., 2010). In
addition, SigB represses a third important regulator of S. aureus
biofilm formation, the accessory gene regulator (agr) system,
which induces biofilm dispersal thereby decreasing the total
biomass and increases the expression of hla (Boles and Horswill,
2008; Mitchell et al., 2010; Atalla et al., 2011). In conclusion,
HQNO reduces the production of the toxin hla by increasing
the expression of SigB, leading to an increased expression of
SarA and a decreased expression of agr. Reduced expression of
toxins helps S. aureus to remain intracellular and thus increase its
chances of survival in the human host. The stimulation of sarA by
upregulation of SigB might be counteracted by long chain AHLs,
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which inhibit sarA (Figure 2, right lower panel). The net effect
is probably dependent on the Pseudomonas strain involved since
the production of both factors might be variable between isolates
(Qazi et al., 2006; Fugère et al., 2014).
P. AERUGINOSA AND S. AUREUS IN DUAL
SPECIES BIOFILMS
During dual species biofilm formation, the balance of attacking,
evading and counter-attacking is even more important and
the properties of each strain as well as some environmental
factors will determine if a dual species biofilm will be formed.
For example, the presence of environmental selection pressure,
like antibiotics or the host immune system, stimulates a more
synergistic relationship and biofilm formation as the tolerance of
S. aureus to antibiotics is significantly higher during co-culture
with P. aeruginosa (DeLeon et al., 2014; Kumar and Ting, 2015).
In the following paragraphs we describe how certain extracellular
factors influence the structure, characteristics and composition of
the dual species biofilms (Figure 3).
P. aeruginosa Extracellular
Polysaccharides Are Important in the
Formation of Multi-Species Biofilms
P. aeruginosa produces three main exopolysaccharides (EPS):
alginate, Pel, and Psl, which form the extracellular matrix in
the biofilm and have a structural and protective function (Leid
et al., 2005; Ryder et al., 2007; Colvin et al., 2011, 2012). Pel
and Psl are the main EPS in non-mucoid strains (Colvin et al.,
2012). The Psl polysaccharide is recently identified as repeating
units of glucose-, mannose-, and rhamnose-sugars and is mainly
produced during the attachment phase of the biofilm (Colvin
et al., 2012). Psl-positive strains have an elastic matrix with
highly effective cross-linking of the matrix components (Chew
et al., 2014). Pel is glucose-rich and is mainly involved in pellicle
formation and later stages of biofilm formation (Colvin et al.,
2012). Contrary to Psl, Pel dominant strains form loose biofilm
structures since Pel reduces the effective cross-linking in the
matrix network (Figure 3; Chew et al., 2014). Consequently, Pel-
mediated loosening of the P. aeruginosa biofilm allows S. aureus
to infiltrate into the biofilm and form multi-species biofilms
(Chew et al., 2014). In contrast, the role of Psl in multi-
species biofilm formation is not very clear. Chew et al showed
that co-culture of a Psl-positive strain (PAO1) and S. aureus
resulted in separated microcolonies without much association
between both species (Chew et al., 2014). Billings et al., on
the other hand, showed that S. aureus was incorporated in the
air-liquid interface of a Psl producing P. aeruginosa biofilm.
Both studies use the same biofilm assay and the same P.
aeruginosa strains, PAO1 and mutants derived from PAO1, but
different S. aureus strains. Because the biofilm structure and dual
species interactions are dependent on both P. aeruginosa and
the Staphylococcus strains, this might explain the discrepancy
between the studies. Nonetheless, both studies concluded that
the EPS provides protection against antibiotics to all inhabitants
of the biofilm, even the non-producers, although the biofilm as
a whole is weakened (Billings et al., 2013). More specifically,
Psl functions as a protective barrier against the antibiotics
colistin and polymyxin B, whereas Pel offers a protective barrier
against aminoglycosides (Figure 3; Colvin et al., 2011; Billings
et al., 2013). These findings indicate that a minimum amount
of EPS per cell present in the biofilm is needed for optimal
protection against antibiotics (Billings et al., 2013). These data
suggests, if S. aureus is able to survive killing by P. aeruginosa
and to co-exist in a multi-species biofilm, it benefits from
the antimicrobial barrier formed by the P. aeruginosa matrix
components. However, the third EPS, alginate, was not shown
to have an effect on S. aureus and S. epidermidis biofilm
formation. Alginate is mainly associated with chronic infections
as its overproduction leads to the mucoid phenotype that
frequently arises during long-term CF lung infection (Ryder
et al., 2007). The switch to a mucoid phenotype contributes
to the establishment of chronic colonization since alginate
offers structural protection against uptake by macrophages and
antimicrobials by forming a barrier limiting the penetration of
antimicrobials, macrophages and macrophage-derived products,
such as the pro-phagocytic cytokine IFN-γ (Leid et al., 2005;
Ryder et al., 2007). Moreover, Leid et al. suggest that alginate
might cause the transition from acute to chronic infection by
limiting IFN-mediated clearance by macrophages, which is the
main mechanism of bacterial clearance during acute infection
(Leid et al., 2005).
S. aureus Protein a Binds to Psl and Type
IV Pili of P. aeruginosa
In addition to EPS, other extracellular factors are important
in dual species biofilm formation. Yang et al showed that only
P. aeruginosa strains producing type IV pili co-aggregate with
S. aureus in microcolonies (Yang et al., 2011). Type IV pili
probably facilitate biofilm formation by binding to extracellular
DNA (eDNA), which is derived from dead bacteria and part
of the biofilm matrix (Yang et al., 2011). P. aeruginosa strains
defective for the production of type IV pili or even treating the
biofilm with DNAse I was shown to reduce the growth of mixed-
species microcolonies (Yang et al., 2011). Furthermore, using
a single S. aureus laboratory strain, Armbruster et al. showed
inhibition of surface attachment of some P. aeruginosa clinical
isolates due to the secretion of protein A (SpA) by S. aureus. SpA
is a cell-wall associated extracellular adhesive protein of S. aureus
that mediates biofilm formation and disrupts phagocytosis (by
binding to the Fc portion of IgG antibodies) and its secretion
was shown to be increased in artificial sputum (Armbruster
et al., 2016). Secreted SpA was shown to specifically bind both
Psl and type IV pili of P. aeruginosa, stressing the importance
of these two molecules in multispecies interactions (Figure 3;
Armbruster et al., 2016). In a Psl producing P. aeruginosa, all
SpA seem to bind to the Psl, leaving the type IV pili free
to mediate biofilm formation. In absence of Psl, SpA binds
to the PilA component of type IV pili and inhibits adhesion
of P. aeruginosa (Armbruster et al., 2016). Furthermore, SpA
seems to protect P. aeruginosa from phagocytosis, as the Psl-SpA
complex is no longer recognized by anti-Psl IgG antibodies. SpA
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FIGURE 3 | Interactions in mixed species biofilms. Differences in biofilm formation by S. aureus with a Psl- or Pel-dominant P. aeruginosa strain. IgG,
immunoglobulin G.
can also bind to the Fc domain of anti-Psl IgG antibodies and
prevent recognition by neutrophils (Figure 3; Armbruster et al.,
2016).
P. AERUGINOSA AND OTHER
STAPHYLOCOCCI
P. aeruginosa Induces Biofilm Dispersal in
S. epidermidis
The antistaphylococcal molecules produced by P. aeruginosa are
also active against other staphylococci, including S. epidermidis,
although some are more resistant to killing compared to
S. aureus. P. aeruginosa was shown to effectively inhibit
and disrupt established S. epidermidis biofilms and induce
detachment without killing during dual species biofilm formation
(Qin et al., 2009; Pihl et al., 2010a,b). After co-inoculation in
equal proportions, P. aeruginosa and S. epidermidis could coexist
for up to 18 h. After this time point, the S. epidermidis cells
in the biofilm are lysed by P. aeruginosa (Pihl et al., 2010a).
These data suggest that there are two stages in interactions
between P. aeruginosa and S. epidermidis, the first includes
the induction of detachment of viable S. epidermidis cells from
the biofilm, while in the second stage cell lysis causes the
total detachment (Pihl et al., 2010a). Similar to S. aureus, the
effect of P. aeruginosa on S. epidermidis is strain dependent
as some P. aeruginosa strains have a more pronounced effect
on some S. epidermidis strains while others are more resistant
to P. aeruginosa (Pihl et al., 2010b). Nevertheless, extracellular
products that prevent initial attachment of some S. epidermidis
strains to surfaces might be an interesting option for the
development of coatings for indwelling medical devices, like
peritoneal dialysis catheters (Pihl et al., 2013). Moreover, in this
model, P. aeruginosa supernatant components replaced serum
proteins on the catheter surface and reduced S. epidermidis
attachment (Pihl et al., 2013). In addition, exposure of a S.
epidermidis biofilm on a catheter to P. aeruginosa supernatant
also caused dispersal of S. epidermidis (Pihl et al., 2013). The
dispersed cells are, however, not killed making it less suitable
as a treatment option and only interesting as a prevention
strategy.
Yayurea A and B from the S. intermedius
Group Are Quorum-Quenching Molecules
Which Provide Protection against Gram
Negative Bacteria
P. aeruginosa is originally an environmental bacterium and
shares a niche with many other, non-pathogenic staphylococci
like the Staphylococcus intermedius group consisting of
S. delphini, S. intermedius, S. lutrae, S. pseudointermedius
and S. schleiferi. All are common colonizers of various animals
and rarely occur in humans (Simou et al., 2005; Ruscher et al.,
2009). This group of staphylococci produces two low molecular
weight compounds, yayurea A and B, that inhibit the production
of quorum-sensing regulated products in Gram negative
bacteria and provide protection against extracellular compounds
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produced by P. aeruginosa (Chu et al., 2013). For example, the
growth of S. delphini is not suppressed by respiratory toxins
during co-culture with P. aeruginosa. Moreover, S. delphini
is able to completely inhibit the production of pyocyanin
(Chu et al., 2013). The quorum-quenching effect of yayurea
A and B covers a broad spectrum of Gram negative bacteria,
including P. aeruginosa, Serratia marcescens, Vibrio harveyi,
and Chromobacterium subtsugae (Chu et al., 2013). Quenching
of the quorum-sensing system of these Gram negative bacteria
does not kill them but rather maintains their physiological state
as if the cell density is low, even though density is in fact high.
This increases the chances of survival of the staphylococci since
toxin production usually begins at high cell density (Chu et al.,
2013). Surprisingly, other staphylococci seem to be resistant
to both molecules, even though they are not producers (Chu
et al., 2013). Interestingly, S. aureus is protected from killing
by P. aeruginosa when yayurea A and B are added to the
medium without the former having to undergo physiological
changes (SCV formation), amd represent promising candidates
for inhibition studies of P. aeruginosa virulence and biofilm
formation.
Variations in CydAB from S. carnosus
Provides Protection Against Killing by
P. aeruginosa
In addition to the S. intermedius group, several other non-
pathogenic staphylococci (S. carnosus, S. piscifermentans, and
S. simulans) seem to be resistant to respiratory toxins secreted
by P. aeruginosa due to alterations in the cydAB genes.
These genes encode the two subunits of cytochrome bd quinol
oxidase, of which homologs are also present in the genomes
of S. aureus and S. epidermidis (Voggu et al., 2006). However,
only the cytochrome bd quinol oxidase of the first group is
resistant to the respiratory toxin, pyocyanin (Voggu et al.,
2006). Furthermore, cloning of the S. carnosus cydAB cluster
into S. aureus confers resistance to respiratory inhibitors
produced by P. aeruginosa (Voggu et al., 2006). Further
research showed that, whereas the CydA subunit is more
conserved in staphylococci, CydB underwent a microevolution
with relatively higher identity within than between the groups
of pathogenic and non-pathogenic staphylococci (Voggu et al.,
2006). This asymmetric evolution of CydB could be explained
by the fact that the non-pathogenic staphylococci frequently
inhabit the same environment as Pseudomonas spp. and
were therefore selected for a higher resistance to respiratory
toxins.
CONCLUDING REMARKS
Both P. aeruginosa and staphylococci are highly versatile
organisms, which readily adapt to a wide variety of environments
and stress factors. In the first glance, these bacteria seem to
have an antagonistic relationship as P. aeruginosa produces a
wide variety of molecules inhibiting staphylococci and frequently
outcompetes S. aureus and S. epidermidis during co-culture. This
antagonistic behavior is mainly shown during planktonic growth
and under traditional culture conditions, where no host factors
or antibiotics are present. However, under some in vitro and
in vivo circumstances, both bacteria are able to co-exist and
form dual species biofilms. These circumstances are dependent
on a combination of strain-dependent properties of both species
and the presence or absence of certain environmental factors
like antibiotics or host factors, the sum of which might
tip the balance toward either killing or co-existence. The
presence of some sort of selection pressure or presence of a
preformed matrix seems to favor dual species biofilm formation
whereas planktonic co-culture without selection pressure leads
to domination of P. aeruginosa. Interspecies competition often
leads to an increased production of virulence factors in both P.
aeruginosa and S. aureus, which are also harmful to the human
host. In addition, escaping the antistaphylococcal compounds
results in a more stress-resistant phenotype of S. aureus, which
is more difficult to be cleared by the immune system, to
be eradicated by antibiotics and to be detected in diagnostic
cultures. Furthermore, the presence of an extracellular matrix
was shown to be beneficial for all biofilm inhabitants, providing
protection against classical antibiotics and the host immune
system, although the exact composition might be variable
depending on the species present and the environment. The role
of these matrix components (exopolysaccharides, eDNA, matrix
proteins, host-derived factors etc.) in interspecies interactions
and their role in disease pathogenesis provides an exciting
opportunity for future research toward better patient care.
When strains are co-existing for a longer time, they might
evolve to a phenotype that is better adapted to the presence
of the other. For example, non-pathogenic staphylococci that
are frequently encountering P. aeruginosa have developed
strategies to continue growing in the presence of P. aeruginosa
antistaphylcoccal compounds, indicating parallel evolution.
Moreover, S. aureus and P. aeruginosa strains isolated from
the same chronic CF lung infection are less sensitive to, and
produce less, HQNO, respectively. This strain adaptation and
the underestimation of the co-existence of P. aeruginosa and
S. aureus might still have a large impact on the clinical outcome
of a patient and therefore should be a subject of continuing
investigation.
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